TRAF6 and neoplasm: In paclitaxel-resistant cells, DRAK1 protein is degraded by the SPOP through K48-linked polyubiquitination-mediated proteasomal degradation, leading to an increase in TRAF6 levels and subsequent TRAF6-mediated NF-κB activation, which promotes tumor progression 77.